Quinn Opportunity Partners’s Maravai LifeSciences MRVI Stock Holding History

Quinn Opportunity Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$750K	Hold	265,070	–	–	0.04%	232
2025 Q4	$861K	Hold	265,070	–	–	0.04%	240
2025 Q3	$761K	Hold	265,070	–	–	0.05%	208
2025 Q2	$639K	Hold	265,070	–	–	0.05%	226
2025 Q1	$586K	Buy	265,070 +231,084	+680%	+$913K	0.04%	261
2024 Q4	$185K	Hold	33,986	–	–	0.01%	331
2024 Q3	$282K	Hold	33,986	–	–	0.03%	230
2024 Q2	$243K	Sell	33,986 -22,014	-39%	-$190K	0.03%	220
2024 Q1	$486K	Hold	56,000	–	–	0.05%	174
2023 Q4	$367K	Hold	56,000	–	–	0.04%	174
2023 Q3	$560K	Buy	56,000 +40,000	+250%	+$439K	0.07%	156
2023 Q2	$199K	Buy	+16,000	New	+$216K	0.03%	185

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quinn Opportunity Partners's MRVI Position: Q1 2026 in Review

Quinn Opportunity Partners held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 265,070 shares worth $750K. The position accounts for 0.04% of the portfolio, ranked #232.

Quinn Opportunity Partners first reported a position in MRVI in Q2 2023 and has held it in 12 quarters since. The position peaked at $861K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Quinn Opportunity Partners held 265,070 shares of Maravai LifeSciences worth $750K as of Q1 2026.
Quinn Opportunity Partners left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up 0.04% of Quinn Opportunity Partners's portfolio in Q1 2026, its #232 holding.
Quinn Opportunity Partners first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 12 quarters since.
Quinn Opportunity Partners's Maravai LifeSciences position peaked at $861K in Q4 2025.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.